The current DFFN market cap is 8.97M. The company's latest EPS is USD -7.6464 and P/E is -0.58.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 4.65M |
Operating Income | -2.92M | -4.25M | -4.27M | -2.29M | 1.23M |
Net Income | -2.8M | -4.08M | -4.09M | -2.11M | 6.4M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -18.96M | -11.55M | -15.98M | -24.68M | -15.97M |
Net Income | -26.62M | -11.8M | -16.14M | -24.1M | -15.59M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 26.32M | 22.64M | 18.41M | 15.7M | 12.04M |
Total Liabilities | 2.27M | 2.42M | 2.13M | 1.47M | 2.46M |
Total Equity | 24.05M | 20.22M | 16.28M | 14.23M | 9.57M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 18.2M | 24.11M | 27.73M | 37.84M | 22.64M |
Total Liabilities | 2.59M | 3.98M | 2.92M | 2.93M | 2.42M |
Total Equity | 15.61M | 20.13M | 24.81M | 34.91M | 20.22M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -11.5M | -14.97M | -4.97M | -7.61M | -4.91M |
Investing | -19.24M | -12.24M | 9.5M | 12.5M | N/A |
Financing | 5k | 5k | N/A | N/A | 11.24M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -10.77M | -9.86M | -13.55M | -14.5M | -14.97M |
Investing | N/A | N/A | N/A | 4k | -12.24M |
Financing | 9.87M | 16.04M | 17.89M | 33.3M | 5k |
Market Cap | 8.97M |
Price to Earnings Ratio | -0.58 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.89 |
Price to Book Ratio | 0.44 |
Dividend Yield | - |
Shares Outstanding | 2.04M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -32.72% |
52 Week High | 7.785 |
52 Week Low | 4.14 |
Spread (Intraday) | 0.02 (0.44%) |
Company Name | Diffusion Pharmaceuticals Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.cervomed.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.